{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:00:27Z","timestamp":1793898027233,"version":"4.8.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["JP18H00468"],"award-info":[{"award-number":["JP18H00468"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["JP20H01087"],"award-info":[{"award-number":["JP20H01087"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We aimed to identify disease-specific surface proteins on extracellular vesicles (EVs) as novel serum biomarkers of PM\/DM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed liquid chromatography\u2013tandem mass spectrometry (LC\/MS) on purified EVs from sera of 10 PM\/DM patients, 23 patients with other autoimmune diseases and 10 healthy controls (HCs). We identified membrane proteins preferentially present in EVs of PM\/DM patients by bioinformatics and biostatistical analyses. We developed an EV sandwich ELISA for directly detecting serum EVs expressing disease-specific membrane proteins and evaluated their clinical utility using sera from 54 PM\/DM, 24 RA, 20 SLE, 13 SSc and 25 Duchenne and Becker types of muscular dystrophy (DMD\/BMD) patients and 36 HCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>LC\/MS analysis identified 1220 proteins in serum EVs. Of these, plexin D1 was enriched in those from PM\/DM patients relative to HCs or patients without PM\/DM. Using a specific EV sandwich ELISA, we found that levels of plexin D1+ EVs in serum were significantly greater in PM\/DM patients than in HCs or RA, SLE or DMD\/BMD patients. Serum levels of plexin D1+ EVs were greater in those PM\/DM patients with muscle pain or weakness. Serum levels of plexin D1+ EVs were significantly correlated with levels of aldolase (rs\u2009=\u20090.481), white blood cells (rs\u2009=\u20090.381), neutrophils (rs\u2009=\u20090.450) and platelets (rs\u2009=\u20090.408) in PM\/DM patients. Finally, serum levels of plexin D1+ EVs decreased significantly in patients with PM\/DM in clinical remission after treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We identified levels of circulating plexin D1+ EVs as a novel serum biomarker for PM\/DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab588","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T19:10:59Z","timestamp":1626981059000},"page":"1669-1679","source":"Crossref","is-referenced-by-count":12,"title":["Identification of plexin D1 on circulating extracellular vesicles as a potential biomarker of polymyositis and dermatomyositis"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-8151","authenticated-orcid":false,"given":"Kenichi","family":"Uto","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital, Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ueda","sequence":"additional","affiliation":[{"name":"Project for Personalized Cancer Medicine, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaichi","family":"Okano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital, Kobe"},{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5289-139X","authenticated-orcid":false,"given":"Kengo","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Center for Rheumatic Disease, Shinko Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakamachi","sequence":"additional","affiliation":[{"name":"Administration Department, Kobe University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital, Kobe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Awano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Morinobu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Kawano","sequence":"additional","affiliation":[{"name":"Integrated Clinical Education Center, Kobe University Hospital, Kobe, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Saegusa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital, Kobe"},{"name":"Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"2022041112494857500_keab588-B1","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(03)14862-3","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"2022041112494857500_keab588-B2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"2022041112494857500_keab588-B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"2022041112494857500_keab588-B4","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"2022041112494857500_keab588-B5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in inflammatory myopathies\u2014an expanded definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"key":"2022041112494857500_keab588-B6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cca.2015.02.007","article-title":"Discovery of new biomarkers of idiopathic inflammatory myopathy","volume":"444","author":"Lu","year":"2015","journal-title":"Clin Chim Acta"},{"key":"2022041112494857500_keab588-B7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2022041112494857500_keab588-B8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","article-title":"Membrane vesicles as conveyors of immune responses","volume":"9","author":"Th\u00e9ry","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2022041112494857500_keab588-B9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","article-title":"Regulation of immune responses by extracellular vesicles","volume":"14","author":"Robbins","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"2022041112494857500_keab588-B10","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1172\/JCI81131","article-title":"Regulation of chronic inflammatory and immune processes by extracellular vesicles","volume":"126","author":"Robbins","year":"2016","journal-title":"J Clin Invest"},{"key":"2022041112494857500_keab588-B11","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/art.40076","article-title":"Review: extracellular vesicles in joint inflammation","volume":"69","author":"Foers","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2022041112494857500_keab588-B12","doi-asserted-by":"crossref","first-page":"102540","DOI":"10.1016\/j.jaut.2020.102540","article-title":"Extracellular vesicles and lupus nephritis \u2013 new insights into pathophysiology and clinical implications","volume":"115","author":"Zhao","year":"2020","journal-title":"J Autoimmun"},{"key":"2022041112494857500_keab588-B13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mus.21311","article-title":"Measurement of platelet-derived microparticle levels using an enzyme-linked immunosorbent assay in polymyositis and dermatomyositis patients","volume":"39","author":"Shirafuji","year":"2009","journal-title":"Muscle Nerve"},{"key":"2022041112494857500_keab588-B14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.imlet.2009.12.018","article-title":"Increased serum concentration of immune cell derived microparticles in polymyositis\/dermatomyositis","volume":"128","author":"Baka","year":"2010","journal-title":"Immunol Lett"},{"key":"2022041112494857500_keab588-B15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12969-019-0347-0","article-title":"Plasma exosomes from children with juvenile dermatomyositis are taken up by human aortic endothelial cells and are associated with altered gene expression in those cells","volume":"17","author":"Jiang","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"2022041112494857500_keab588-B16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/BOR.0000000000000748","article-title":"Nonimmune mechanisms in idiopathic inflammatory myopathies","volume":"32","author":"Loredo Martinez","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2022041112494857500_keab588-B17","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMra1704286","article-title":"Circulating extracellular vesicles in human disease","volume":"379","author":"Shah","year":"2018","journal-title":"N Engl J Med"},{"key":"2022041112494857500_keab588-B18","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"2022041112494857500_keab588-B19","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1038\/srep06232","article-title":"Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes","volume":"4","author":"Ueda","year":"2014","journal-title":"Sci Rep"},{"key":"2022041112494857500_keab588-B20","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1038\/ncomms4591","article-title":"Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen","volume":"5","author":"Yoshioka","year":"2014","journal-title":"Nat Commun"},{"key":"2022041112494857500_keab588-B21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"2022041112494857500_keab588-B22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"2022041112494857500_keab588-B23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2022041112494857500_keab588-B24","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2022041112494857500_keab588-B25","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2022041112494857500_keab588-B26","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2022041112494857500_keab588-B27","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022041112494857500_keab588-B28","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.3390\/ijms21186965","article-title":"Semaphorin4A\u2013Plexin D1 axis induces Th2 and Th17 while represses Th1 skewing in an autocrine manner","volume":"21","author":"Carvalheiro","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2022041112494857500_keab588-B29","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.4049\/jimmunol.1003464","article-title":"Plexin-D1 is a novel regulator of germinal centers and humoral immune responses","volume":"186","author":"Holl","year":"2011","journal-title":"J Immunol"},{"key":"2022041112494857500_keab588-B30","doi-asserted-by":"crossref","first-page":"e43333","DOI":"10.1371\/journal.pone.0043333","article-title":"Plexin-B2 and plexin-D1 in dendritic cells: expression and IL-12\/IL-23p40 production","volume":"7","author":"Holl","year":"2012","journal-title":"PLoS One"},{"key":"2022041112494857500_keab588-B31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.1601093","article-title":"Chemorepellent semaphorin 3E negatively regulates neutrophil migration in vitro and in vivo","volume":"198","author":"Movassagh","year":"2017","journal-title":"J Immunol"},{"key":"2022041112494857500_keab588-B32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2172-9-43","article-title":"Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis","volume":"9","author":"Chen","year":"2008","journal-title":"BMC Immunol"},{"key":"2022041112494857500_keab588-B33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0002-9343(81)90363-6","article-title":"Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis","volume":"71","author":"Shoenfeld","year":"1981","journal-title":"Am J Med"},{"key":"2022041112494857500_keab588-B34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/dvdy.10159","article-title":"PLEXIN-D1, a novel plexin family member, is expressed in vascular endothelium and the central nervous system during mouse embryogenesis","volume":"225","author":"van der Zwaag","year":"2002","journal-title":"Dev Dyn"},{"key":"2022041112494857500_keab588-B35","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1172\/JCI42118","article-title":"Sema3E\u2013Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice","volume":"120","author":"Casazza","year":"2010","journal-title":"J Clin Invest"},{"key":"2022041112494857500_keab588-B36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-015-0749-4","article-title":"Plexin-D1\/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis","volume":"17","author":"Mazzotta","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2022041112494857500_keab588-B37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1515\/CCLM.2010.179","article-title":"Biochemical markers of muscular damage","volume":"48","author":"Brancaccio","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"2022041112494857500_keab588-B38","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/jnnp.2008.161448","article-title":"High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology","volume":"80","author":"Nozaki","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022041112494857500_keab588-B39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1756-185X.13770","article-title":"Baseline characteristics and long-term outcomes of eosinophilic fasciitis in 89 patients seen at a single center over 20 years","volume":"23","author":"Mango","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2022041112494857500_keab588-B40","first-page":"548","article-title":"Isolated elevation of aldolase in the serum of myositis patients: a potential biomarker of damaged early regenerating muscle cells","volume":"30","author":"Casciola-Rosen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"2022041112494857500_keab588-B41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy","volume":"201","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"2022041112494857500_keab588-B42","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.40883","article-title":"Myositis autoantigen expression correlates with muscle regeneration but not autoantibody specificity","volume":"71","author":"Pinal-Fernandez","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2022041112494857500_keab588-B43","doi-asserted-by":"crossref","first-page":"e134189","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"key":"2022041112494857500_keab588-B44","doi-asserted-by":"crossref","first-page":"15729","DOI":"10.1038\/ncomms15728","article-title":"Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2","volume":"8","author":"Takasugi","year":"2017","journal-title":"Nat Commun"},{"key":"2022041112494857500_keab588-B45","doi-asserted-by":"crossref","first-page":"e132447","DOI":"10.1172\/jci.insight.132447","article-title":"EPHB2 carried on small extracellular vesicles induces tumor angiogenesis via activation of ephrin reverse signaling","volume":"4","author":"Sato","year":"2019","journal-title":"JCI Insight"},{"key":"2022041112494857500_keab588-B46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-018-0482-7","article-title":"Coupling of bone resorption and formation by RANKL reverse signalling","volume":"561","author":"Ikebuchi","year":"2018","journal-title":"Nature"},{"key":"2022041112494857500_keab588-B47","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00018-016-2137-x","article-title":"Transmembrane semaphorins, forward and reverse signaling: have a look both ways","volume":"73","author":"Battistini","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"2022041112494857500_keab588-B48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41590-018-0108-0","article-title":"Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization","volume":"19","author":"Kang","year":"2018","journal-title":"Nat Immunol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab588\/40564793\/keab588.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1669\/43356005\/keab588.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/4\/1669\/43356005\/keab588.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T12:53:31Z","timestamp":1649681611000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/4\/1669\/6326774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,7,23]]},"published-print":{"date-parts":[[2022,4,11]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab588","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,7,23]]}}}